APA

Fairhurst R. A., Marsilje T. H., Stutz S., Boos A., Niklaus M., Chen B., Jiang S., Lu W., Furet P., McCarthy C., Stauffer F., Guagnano V., Vaupel A., Michellys P., Schnell C. & Jeay S. (20161213). Optimisation of a 5-[3-phenyl-(2-cyclic-ether)-methyl-ether]-4-aminopyrrolopyrimidine series of IGF-1R inhibitors. : Bioorganic & medicinal chemistry letters.

Chicago

Fairhurst Robin A, Marsilje Thomas H, Stutz Stefan, Boos Andreas, Niklaus Michel, Chen Bei, Jiang Songchun, Lu Wenshuo, Furet Pascal, McCarthy Clive, Stauffer Frédéric, Guagnano Vito, Vaupel Andrea, Michellys Pierre-Yves, Schnell Christian and Jeay Sébastien. 20161213. Optimisation of a 5-[3-phenyl-(2-cyclic-ether)-methyl-ether]-4-aminopyrrolopyrimidine series of IGF-1R inhibitors. : Bioorganic & medicinal chemistry letters.

Harvard

Fairhurst R. A., Marsilje T. H., Stutz S., Boos A., Niklaus M., Chen B., Jiang S., Lu W., Furet P., McCarthy C., Stauffer F., Guagnano V., Vaupel A., Michellys P., Schnell C. and Jeay S. (20161213). Optimisation of a 5-[3-phenyl-(2-cyclic-ether)-methyl-ether]-4-aminopyrrolopyrimidine series of IGF-1R inhibitors. : Bioorganic & medicinal chemistry letters.

MLA

Fairhurst Robin A, Marsilje Thomas H, Stutz Stefan, Boos Andreas, Niklaus Michel, Chen Bei, Jiang Songchun, Lu Wenshuo, Furet Pascal, McCarthy Clive, Stauffer Frédéric, Guagnano Vito, Vaupel Andrea, Michellys Pierre-Yves, Schnell Christian and Jeay Sébastien. Optimisation of a 5-[3-phenyl-(2-cyclic-ether)-methyl-ether]-4-aminopyrrolopyrimidine series of IGF-1R inhibitors. : Bioorganic & medicinal chemistry letters. 20161213.